Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-03-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(02)08090-XPMID 11937179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study).

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study

  2001cited by this paper
• Impact of diabetes on cardiac structure and function: the strong heart study.

  2000cited by this paper
• [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension].

  2000cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2

  2000cited by this paper
• Guidelines for the management of hypertension.

  2000cited by this paper
• Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

  2000cited by this paper
• Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

  1999cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

  1999cited by this paper
• The renin-angiotensin-aldosterone system: a specific target for hypertension management.

  1999cited by this paper
• Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

  1999cited by this paper
• The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

  1998cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

  1998cited by this paper
• The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.

  1997cited by this paper
• Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

  1996cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• An updated coronary risk profile. A statement for health professionals.

  1991cited by this paper
• Diabetes and Cardiovascular Risk Factors: The Framingham Study

  1979cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Anacardic acid mitigates post‑MI cardiac fibrosis via suppressing p38/JNK-GATA3 pathway and H3K9ac‑dependent epigenetic regulation.

  2026cites this paper
• Cost-Effectiveness of Primary Prevention of Stroke in Type 2 Diabetes in the United States: A Microsimulation Analysis.

  2025cites this paper
• Efficacy of Losartan within a Multicomponent Secondary Prevention Strategy for Cardiovascular Events in Post-Ischemic Stroke Patients

  2025cites this paper
• Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers

  2025cites this paper
• Inhibition of the Renin–Angiotensin System Improves Hemodynamic Function of the Diabetic Rat Heart by Restoring Intracellular Calcium Regulation

  2025cites this paper
• Section 9: Pharmacologic Approaches to Glycemic Treatment

  2024cites this paper
• Association between cardiovascular disease risk and incident type 2 diabetes mellitus in individuals with prediabetes: A retrospective cohort study.

  2024cites this paper
• Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies

  2024cites this paper
• Diabetes mellitus tipo 2

  2024cites this paper
• 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association

  2024cites this paper
• Decision making in disaster management: considering the medicated society–a case study

  2024cites this paper
• Effect of active vitamin-D on left ventricular mass index: results of a randomised controlled trial in type 2 diabetes and chronic kidney disease.

  2023cites this paper
• The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension

  2023cites this paper
• Effect of renin–angiotensin system inhibitors on cardiovascular events in hemodialysis patients with hyperphosphatemia: A post hoc analysis of the LANDMARK trial

  2023cites this paper
• 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

  2023cites this paper
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

  2023cites this paper
• The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review

  2023cites this paper
• Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a meta-analysis of randomized trials

  2023cites this paper
• β-Blockers could improve the 28-day and 3-year survival of patients with end-stage renal disease: a retrospective cohort study

  2023cites this paper
• Antitumor Therapy Targeting the Tumor Microenvironment

  2023cites this paper
• [Left ventricular geometry study in black African hypertensives].

  2023cites this paper
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.

  2023cites this paper
• Terpenoids in Diabetic nephropathy: Advances and Therapeutic Opportunities.

  2023cites this paper
• Risk Factors and Prevention

  2022cites this paper
• Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists

  2022cites this paper
• Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease.

  2022cites this paper
• Cost-effectiveness of carotid artery stenting vs endarterectomy: A simulation

  2022cites this paper
• Calculating power for the Finkelstein and Schoenfeld test statistic for a composite endpoint with two components

  2022influential citation
• Formation of Protamine and Zn–Insulin Assembly: Exploring Biophysical Consequences

  2022cites this paper
• Risk factors for hypertension and diabetes comorbidity in a Korean population: A cross-sectional study

  2022cites this paper
• Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations

  2022cites this paper
• VHRM_A_337640 507..515

  2022cites this paper
• Hypertension management in patients with cardiovascular comorbidities.

  2022cites this paper
• Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MIND

  2022cites this paper
• Beneficial effects of carvedilol modulating potassium channels on the control of glucose.

  2022cites this paper
• Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes.

  2022cites this paper
• Hypertensive mediated organ damage evolution in resistant hypertension patients after adding spironolactone.

  2022cites this paper
• Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up

  2022cites this paper
• Hypertension artérielle chez le sujet diabétique

  2022cites this paper
• 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea

  2021cites this paper
• Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

  2021cites this paper
• 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.

  2021cites this paper
• The Goto Kakizaki rat: Impact of age upon changes in cardiac and renal structure, function

  2021cites this paper
• Der österreichische Bluthochdruckpatient in der ärztlichen Praxis: Eine erste Analyse von 20.615 Hypertonikern aus dem LIIFE-IN-LIFE-Projekt-mit Therapieergebnissen nach 12 Monaten bei 9000 Patienten

  2021cites this paper
• ЕВРАЗИЙСКИЕ РЕКОМЕНДАЦИИ ПО ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У БОЛЬНЫХ С ДИАБЕТОМ И ПРЕДИАБЕТОМ (2021)

  2021cites this paper
• Human cell receptors: potential drug targets to combat COVID-19

  2021cites this paper
• Intake of isoflavones reduces the risk of all-cause mortality in middle-aged Japanese

  2021cites this paper
• Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

  2021cites this paper
• Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?

  2021cites this paper
• The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin–adiponectin imbalance

  2021cites this paper
• Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives

  2021cites this paper
• Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma

  2021cites this paper
• Complementary value of ECG and echocardiographic left ventricular hypertrophy for prediction of adverse outcomes in the general population

  2021cites this paper
• Stage A Heart Failure: Modern Strategies for an Effective Prevention.

  2021cites this paper
• A Point System Table to Estimate the Risk of Cardiovascular Events in Patients with Hypertension and Left Ventricular Hypertrophy: The LIFE Study

  2021cites this paper
• A Comparative Study of Tolerability of Losartan versus Atenolol in Essential Hypertension and Their Effect on Lipid Profile

  2021cites this paper
• Increased Backward Wave Pressures Rather than Flow Explain Age-Dependent Heart Rate Effects on Central, But not Peripheral Arterial Pressure

  2021cites this paper
• Is there any correlation between Magnesium status and depression in elderly people? A descriptive-analytical study among Tehran-nursing home residents

  2021cites this paper
• Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system

  2021cites this paper
• Relationship of Cholesterol Levels with Gestational Hypertension and Preeclampsia During Pregnancy

  2021cites this paper
• Pharmacogenomics and Heart Failure Patients on Carvedilol

  2020cites this paper
• De la insuficiencia cardiaca a la diabetes. ¿Existe un mecanismo común?

  2020cites this paper
• Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome

  2020cites this paper
• A Review on Diabetic Nephropathy Disease : Risk Factors and Complications D Review

  2020cites this paper
• Assessment of Association between Antihypertensive Drug Use and Occurrence of New-onset Diabetes in South Indian Patients

  2020cites this paper
• Recent Guideline for the Management of Hypertension in Patients with Diabetes

  2020cites this paper
• Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension

  2020cites this paper
• Evidence in Guidelines for Treatment of Coronary Artery Disease.

  2020cites this paper
• Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society

  2020cites this paper
• Precision medicine for heart failure based on molecular mechanisms The Research Achievement Award Lecture.

  2020cites this paper
• Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　- A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society.

  2020cites this paper
• Heart failure in diabetes mellitus: an updated review.

  2020cites this paper
• Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician

  2020cites this paper
• Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial

  2020cites this paper
• The relationship between resting heart rate and new‐onset microalbuminuria in people with type 2 diabetes: An 8‐year follow‐up study

  2020cites this paper
• Microvascular Alterations in Diabetes: Focus on Small Resistance Arteries

  2020cites this paper
• Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea

  2020cites this paper
• Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis

  2020cites this paper
• FUNCTIONAL IMPACT OF ANGIOTENSINOGEN SPECIFIC DOMAINS ON ANGIOTENSIN II-MEDIATED FUNCTIONS

  2020cites this paper
• Diretrizes Brasileiras de Hipertensão Arterial – 2020

  2020cites this paper
• Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

  2020cites this paper
• Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Advances and challenges in the electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive individuals.

  2020cites this paper
• Phenylethanol Glycosides Protect Myocardial Hypertrophy Induced by Abdominal Aortic Constriction via ECE-1 Demethylation Inhibition and PI3K/PKB/eNOS Pathway Enhancement

  2020cites this paper
• Diabetes and the Cardiovascular System

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Prognostic significance of body mass index‐adjusted criteria for left ventricular hypertrophy

  2020cites this paper
• Features of postoperative therapy in patients with type ІІ diabetes

  2020cites this paper
• LC-MS method development for the quantitation of potential genotoxic impurity 2-Methyl-6-nitro aniline in Telmisartan API

  2020cites this paper
• Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea

  2020cites this paper
• Dietary Diversity and All-Cause and Cause-Specific Mortality in Japanese Community-Dwelling Older Adults

  2020cites this paper
• Hypertension, Left Ventricular Hypertrophy, and Heart Failure

  2020cites this paper
• Antihypertensive Therapie bei Typ 2-Diabetes: State of the Art 2002

  2020influential citation
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• Clinical and Biological Study on the Relevance of Hiperfibrinogenemyme in Cardiovascular Pathology of the Obez Patient

  2019cites this paper
• Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients

  2019cites this paper
• Effect of Losartan on Different Biochemical Parameters in Essential Hypertensive Patients

  2019cites this paper
• Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.

  2019cites this paper
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

  2019cites this paper